PT1651665E - Método para a purificação de uma proteína não imunoglobulina compreendendo um domínio de tipo imunoglubolina (tipo ig) - Google Patents

Método para a purificação de uma proteína não imunoglobulina compreendendo um domínio de tipo imunoglubolina (tipo ig) Download PDF

Info

Publication number
PT1651665E
PT1651665E PT04745072T PT04745072T PT1651665E PT 1651665 E PT1651665 E PT 1651665E PT 04745072 T PT04745072 T PT 04745072T PT 04745072 T PT04745072 T PT 04745072T PT 1651665 E PT1651665 E PT 1651665E
Authority
PT
Portugal
Prior art keywords
immunoglobulin
purification
domain
protein
immunoglobulin protein
Prior art date
Application number
PT04745072T
Other languages
English (en)
Inventor
Ilana Belzer
Boris Schwartsburd
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Publication of PT1651665E publication Critical patent/PT1651665E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
PT04745072T 2003-08-07 2004-08-05 Método para a purificação de uma proteína não imunoglobulina compreendendo um domínio de tipo imunoglubolina (tipo ig) PT1651665E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL15730903A IL157309A0 (en) 2003-08-07 2003-08-07 Method for the purification of a non-immunoglobulin protein

Publications (1)

Publication Number Publication Date
PT1651665E true PT1651665E (pt) 2008-09-08

Family

ID=32652322

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04745072T PT1651665E (pt) 2003-08-07 2004-08-05 Método para a purificação de uma proteína não imunoglobulina compreendendo um domínio de tipo imunoglubolina (tipo ig)

Country Status (17)

Country Link
US (1) US7550563B2 (pt)
EP (1) EP1651665B1 (pt)
JP (1) JP4630280B2 (pt)
AT (1) ATE402948T1 (pt)
AU (1) AU2004263389B2 (pt)
CA (1) CA2532913C (pt)
CY (1) CY1110441T1 (pt)
DE (1) DE602004015468D1 (pt)
DK (1) DK1651665T3 (pt)
ES (1) ES2308202T3 (pt)
HR (1) HRP20080408T3 (pt)
IL (2) IL157309A0 (pt)
NO (1) NO331035B1 (pt)
PL (1) PL1651665T3 (pt)
PT (1) PT1651665E (pt)
SI (1) SI1651665T1 (pt)
WO (1) WO2005014621A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7420756B2 (en) * 2003-05-20 2008-09-02 Donnelly Corporation Mirror reflective element
GB0524225D0 (en) * 2005-11-29 2006-01-04 Amersham Biosciences Ab Methods and apparatus for detecting and measuring the concentration of a substance in a solution
US7999085B2 (en) * 2007-01-09 2011-08-16 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US7748856B2 (en) * 2007-05-23 2010-07-06 Donnelly Corporation Exterior mirror element with integral wide angle portion
AU2008274195B2 (en) * 2007-07-11 2013-09-05 Novo Nordisk A/S Purification of factor VIII using a mixed-mode or multimodal resin
ES2767135T3 (es) * 2011-10-19 2020-06-16 Novimmune Sa Métodos para purificar anticuerpos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ190603A (en) 1978-06-07 1982-03-23 Nat Res Dev Heat-stable -galactosidase derived from bacillus stearothermophilus hydrolysis of lactose
IL122818A0 (en) * 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
AU1368300A (en) * 1999-07-09 2001-01-30 Universite De Liege Cold-active beta galactosidase, the process for its preparation and the use thereof
IL147412A0 (en) 2001-12-31 2002-08-14 Yeda Res & Dev The use of il6r/il6 chimera in nerve cell regeneration

Also Published As

Publication number Publication date
CY1110441T1 (el) 2015-04-29
EP1651665A1 (en) 2006-05-03
CA2532913A1 (en) 2005-02-17
ATE402948T1 (de) 2008-08-15
IL173506A0 (en) 2006-07-05
US7550563B2 (en) 2009-06-23
US20070032638A1 (en) 2007-02-08
NO331035B1 (no) 2011-09-19
HRP20080408T3 (en) 2008-09-30
NO20061015L (no) 2006-03-01
PL1651665T3 (pl) 2009-01-30
WO2005014621A1 (en) 2005-02-17
SI1651665T1 (sl) 2008-10-31
ES2308202T3 (es) 2008-12-01
IL157309A0 (en) 2004-02-19
AU2004263389B2 (en) 2009-12-10
EP1651665B1 (en) 2008-07-30
AU2004263389A1 (en) 2005-02-17
JP2007523882A (ja) 2007-08-23
CA2532913C (en) 2012-07-31
JP4630280B2 (ja) 2011-02-09
DK1651665T3 (da) 2008-10-27
DE602004015468D1 (de) 2008-09-11
IL173506A (en) 2011-04-28

Similar Documents

Publication Publication Date Title
ATE408624T1 (de) Verfahren zur reinigung von fsh
NO983431L (no) Anti-klöemidler
HUP0402029A2 (hu) Peptidalapú multimer célzott kontrasztanyagok
ATE360647T1 (de) Verfahren zur aufreinigung von il-18-bindendem protein
PL374966A1 (en) Follistatin domain containing proteins
PL1682530T3 (pl) Podstawione pirolo-indole jako inhibitory PAI-1
WO2004092199A3 (en) Method for identifying modulators of g protein coupled receptor signaling
ME00185B (me) Specifični agensi koji vezuju humani angiopoetin-2
IL173506A0 (en) Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain
EA200601029A1 (ru) Способ очистки фсг
CY1105980T1 (el) Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
HK1082509A1 (en) Method for isolating an intestinal cholesterol binding protein
DE502005003382D1 (de) Verfahren zur destillativen aufarbeitung von tetrahydrofuran
DE60325737D1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
ZA200406449B (en) Follistatin domain containing proteins
NO20051938L (no) Promoter til IL-18BP, dens fremstilling og anvendelse
WO2005017177A3 (en) Modulators of nod1 signaling
DE60328621D1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
TW200722435A (en) Purification of proteins with cationic surfactant
TW200504218A (en) Methods for preventing gluconoylation of proteins
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.
WO2005034838A3 (en) Protease inhibitors